Both in Pharmaceuticals
CytomX Therapeutics vs Ovid Therapeutics
Over the past year CTMX returned −44.5% and OVID returned +73.9%; their daily moves had a correlation of 0.21.
CTMX −44.5% OVID +73.9%Growth of $1, one year, split-adjusted
| Metric | CTMX | OVID |
|---|---|---|
| Price | $2.18 | $2.40 |
| Market cap | $475.0M | $468.7M |
| Today | −2.24% | +0.42% |
| 1 month | −15.5% | +2.6% |
| 6 months | −46.6% | −15.2% |
| Year to date | −48.8% | +47.2% |
| 1 year | −38.9% | +72.7% |
| Revenue growth (YoY) | −92.4% | −88.3% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1457.4% | −2047.6% |
| P/E (TTM) | — | — |
| Price / sales | 26.0× | 296.1× |
| Net cash | $330.3M | $117.2M |
| Dividend yield | — | — |
| Volatility (60d) | 67.6% | 59.0% |
| Short % of float | 21.4% | 10.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).